Upcoming Webinars

Extractables and Leachables have been used interchangeablely for too long. Are we still confused?

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Don DeCou, Extractable and Leachable Technology Manager at West Pharmaceutical Services
25th March 2019


From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD?

Presented by Perrine Rouel, Scientist - Up Stream Processing, The Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Application Specialist – Ambr Technology KAM Europe at Sartorius Stedim Biotech
27th March 2019


Introducing Chromassette®, a modular chromatography platform enabling next-generation bioprocess purification.

Presented by Ping Huang, Director, Head of DS BioProcesses, OED, Abbvie at Redwood and Masayoshi Nagaya, Sr. Global Technology Manager at JSR Micro Inc
05th April 2019


Case-by-Case Assessment of Bioburden (CCAB): A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics

Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche and Mathilde Arnault, Research Scientist, BioMonitoring R&D, Merck KGaA, Darmstadt, Germany
09th April 2019


Application of Multivariate Data Analysis in Process Analytical Technologies

Presented by Hossein Sahraei, Data Scientist, Sanofi Pasteur
10th April 2019


Applying Low Frequency Raman to QbD in Pharmaceutical Development

Presented by John Wasylyk, Senior Principal Scientist at Bristol-Myers Squibb Company and James Carriere, Product Line Manager for Coherent’s THz-Raman product line
26th April 2019


Analysing Complex Data in the Pharmaceutical Industry: The Case for Multivariate Analysis

Presented by Presented by Mike Tobyn, Research Fellow at Bristol-Myers Squibb
02nd May 2019


PDA Technical Report on Low Endotoxin Recovery: Implications to the Industry

Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche
03rd May 2019


Employing Hot Melt Extrusion As a Cost Effective Method of Increasing Solubility Of Water Insoluble API’s

Presented by Dennis Douroumis, Professor in Pharmaceutical Technology and Process Engineering at University of Greenwich and Dr.-Ing Margarethe Richter, Pharma Application Specialist at Thermo Fisher Scientific
07th May 2019


Do Extractable Protocols Truly Help – An End User Perspective

Presented by Ekta Mahajan, Genentech/Roche
08th May 2019


Characterization of Subvisible Particles in Protein and Viral Vaccines

Presented by Marina Kirkitadze,Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur
21st May 2019


Mapping Future Technology Needs For Real Time Release Testing

Presented by Dr Udayanath Aich, Associate Director at Bristol-Myers Squibb
22nd May 2019


Regulatory Strategies and Case Studies for Rapid Sterility Testing of Gene and Cell Therapy Products

Presented by Dr. Michael J. Miller, President of Microbiology Consultants, LLC
23rd May 2019


Viral Safety by Design for Cell and Gene Therapy Products

Presented by Mark Plavsic, Chief Technology Officer at Lysogene and Archie Lovatt, Life Sciences Biosafety Scientific Director at SGS
24th May 2019


New Drug Product Development Using Continuous Manufacturing

Presented by Giustino Di Pretoro, Associate Director Drug Product Development an Johnson and Johnson And Dr. Robin Meier, Manager Scientific Operations at L.B. Bohle Maschinen
28th May 2019


Implementation Of An Affordable And Scalable Manufacturing Strategy For Gene Therapy Products

Presented by Bastiaan Leewis, MSAT manager of Industrialization at MeiraGTx
29th May 2019


Innovative solutions from Industry 4.0

Presented by Michael May, President and CEO, CCRM at Centre For Commercialization Of Regenerative Medicine
10th June 2019


HME lipidic Pellets for Paediatric Application. An Investigation of the Effect and Stability on Drug Dissolutions

Presented by Dennis Douroumis, Professor in Pharmaceutical Technology and Process Engineering at University of Greenwich
11th June 2019


Pharmaceutical Forensics for Safe Manufacturing and Supply

Presented by Ravi Kalyanaraman, Director at Bristol-Myers Squibb and Jeremy Peters, Scientist at Bristol-Myers Squibb and Dr. Robert Heintz, Senior Applications Specialist at Thermo Fisher Scientific
14th June 2019


Innovation in Biomanufacturing Plants

Presented by Chris Chen PhD, CEO at WuXi Biologics and Dr. Sébastien Ribault, Senior Director, Global Delivery and Sales, BioReliance® End-to-End Solutions at Merck.
20th June 2019


mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO at Genor Biopharma, Walvax Bio Group and Sarah (Xuyu) Wang, Head of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim Biotech
24th June 2019


Chemical and Physical Transformation Monitoring by Raman and IR Spectroscopies in Pharmaceutical Development

Presented by John Wasylyk, Senior Principal Scientist at Bristol-Myers Squibb and Karen Esmonde-White, Senior Marcom Specialist at Kaiser Optical Systems Inc.
01st July 2019


Biopharmaceutical process development – Trends/ Challenges/Opportunities

Presented by Kumar Gaurav, Assistant General Manager - Vaccines and Biologics (R&D) at Panacea Biotec
05th July 2019


Use of Computational Modelling in Specification Setting and Establishing Control Strategy

Presented by Thomas O'Connor, Scientist at FDA and Sean Bermingham, Head of Formulated Products at PSE Ltd
15th July 2019


Designing production facilities of the future

Presented by Geoffry Hodge, Chief Technical Officer at Unum Therapeutics
30th July 2019


Lifecycle management of single use technologies

Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
05th August 2019


Case Study and Experience on Sanofi’s Implementation of BPOG’s Leachable Risk Assessment Model

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Dujuan Lu, Manager/Global Lead of E&L at SGS
10th September 2019


Alternative And Rapid Microbiological Methods: Microbiology Of The 21st Century

Presented by Presented by Dr Benoit Ramond, Head of Microbiology & Sterile Technology, Sanofi and  Dr. David Jones, Director of New Products & Industry Affairs at Rapid Micro Biosystems
12th September 2019


Cost Considerations for the Application of Continuous Processing

Presented by Narasimha Rao Nedunuri, CEO of CLONZ Biotech
02nd October 2019